Dropout Is the Biggest Threat to Your Trial's Timeline
Patients rarely drop out of a trial because of the science. They drop out because of the flights, the hotel nights, the gas, the lost wages, and the fear — the everyday cost of living around a trial that stipends rarely cover in full. We Are Here facilitates patients and caregivers with the travel, lodging, meals, financial assistance, and day-to-day support through community resources that keeps them enrolled through the final visit.
We Are Here at a Glance
secured for trial participants, over 6 months
of patients still engages at 12 months
self-onboard — most outside normal business hours
vetted US resources & assistance programs
Endorsed & supported by
Every Dropout Puts Your Timeline and Revenue at Risk
Every stage of the journey — screening, enrollment, first fill, refill, follow-up — leaks patients for reasons that have nothing to do with the drug. The literature is clear about why.
Of adult cancer trials fail to complete
One in five never finishes. Nearly 48,000 patients enrolled in trials that reached no answer — most often for lack of accrual, not safety or results.
Stensland et al., JNCI (2014)
Have to spend money out-of-pocket
Early-phase oncology patients spend $1,000+ per month out-of-pocket to participate.
National Library of Medicine, 2024
of clinical trial timeline delays trace back to recruitment and retention failures
4 out of 5 clinical trials face delays rooted in recruitment and retention. These delays end up costing sponsors in replacement and recruitment.
BioPharma Dive
WHERE PATIENTS FALL OUT
Every Dropout Puts Your Timeline, Cost, and Revenue at Risk
Map any oncology drug trial — and the same non-clinical failure points appear. We Are Here sits under all of them, and improves your conversion and retention.
1
Screening
2
Enrollment
3
On Trial
We match patients to vetted resources for —
Financial assistance
Caregiver support
Advocacy & education
Non-trial side-effect resources
Everyday services
Every patient and caregiver is matched to the specific programs they qualify for — and stays connected between the moments your team can see.
Sources: Unger et al., JNCI 2021 · NLM, 2024 · BioPharma Dive, 2023
Two assumptions that don't hold up
Stipends cover it.
Pharma stipends help, but rarely cover the full cost -- parking, childcare, lost wages, co-pays, mental health, and daily life expenses remain unaddressed.
Decentralized trials solve this.
Remote and hybrid designs reduce travel but introduce new barriers -- home health logistics, caregiver strain, connectivity, and the same financial pressures.
WHAT WE DO
Technology-Enabled Retention Infrastructure with a Human in the Loop
Free and discounted travel, hotels, meals, gas cards, childcare, and financial assistance — for the patient and the caregiver. Deployed around a trial, a launch, or a whole franchise, with no site software to install and no new burden on coordinators or staff.
Keep patients in the trial
Matching a patient to a trial is not the same as getting them there. They still have to reach the site — then live near it for weeks. We Are Here's proprietary database includes more than 20,000 resources that can secure free and discounted travel, hotels, meals, and gas cards for patients and their caregivers. Participants have received $10,000–$21,000+ in assistance across six months to help them finish.
Retention


Matching the right resources for each patient needs
Every patient hits a different wall. We Are Here matches 24 patient characteristics against 160 resource characteristics to generate best-fit support instantly — proactive and need-based, including the needs patients don't know to ask about. A navigator reviews and approves every recommendation before it reaches the patient, and the model learns from real outcomes every day.
See retention as it happens
Support you can't measure can't be managed. Sponsors and sites get real-time, aggregate dashboards — support categories used, financial and transportation assistance connected & received , time-to-first-resource, and patient-reported distress and loneliness trends. It's the retention signal you look for, and every figure is anonymized, so no individual patient's data ever crosses the line.

Nightly AI validation confirms every resource link is live, compliant, and -- for financial resources -- actively funded.
PROOF
Engagement your patient app can't get.
Patients meet We Are Here through cancer organizations they already trust — not a brand portal. That's why they're still here a year later.
Beyond the Trial
Enrollment isn't the
finish line.
Patients leave trials for reasons that have nothing to do with the science — and everything to do with the cost and load of participating. See where that load sits today, and where We Are Here picks it up.
Patient Barrier
Covered by the trial today

Financial (lost wages, childcare)
Partial (stipend)
✓
Logistical (travel, relocation, scheduling)
Partial
✓
Emotional (distress, isolation, fear)
Out of scope
✓
Family & caregiver support
Out of scope
✓
Independent and non-promotional: resources are vetted third parties, support is need-based and therapy-agnostic — designed to keep sponsors at arm's length from individual patient decisions.
Dropout Is the Biggest Threat to Your Trial's Timeline
Patients rarely drop out of a trial because of the science. They drop out because of the flights, the hotel nights, the gas, the lost wages, and the fear — the everyday cost of living around a trial that stipends rarely cover in full. We Are Here facilitates patients and caregivers with the travel, lodging, meals, financial assistance, and day-to-day support through community resources that keeps them enrolled through the final visit.
We Are Here at a Glance
secured for trial participants, over 6 months
of patients still engages at 12 months
self-onboard — most outside normal business hours
vetted US resources & assistance programs
Endorsed & supported by
WHERE PATIENTS FALL OUT
Every Dropout Puts Your Timeline, Cost, and Revenue at Risk
Map any oncology trial — and the same non-clinical failure points appear. We Are Here sits under all of them, and improves your retention.
1
Screening
2–3X
2
Enrollment
56%
3
On Trial
53%
The We Are Here support layer
Financial assistance matching
Caregiver support
Advocacy & education
Non-trial side-effect resources
Everyday services
24/7 ∙ self-serve
Every patient and caregiver is matched to the specific programs they qualify for — and stays connected between the moments your team can see.
Sources: Kent Cancer 2013 · Unger JNCI 2019 · Unger JCO 2013
Every Dropout Puts Your Timeline and Revenue at Risk
Every stage of the journey — screening, enrollment, first fill, refill, follow-up — leaks patients for reasons that have nothing to do with the drug. The literature is clear about why.
Of adult cancer trials fail to complete
One in five never finishes. Nearly 48,000 patients enrolled in trials that reached no answer — most often for lack of accrual, not safety or results.
Stensland et al., JNCI (2014)
Have to spend money out-of-pocket
Early-phase oncology patients spend $1,000+ per month out-of-pocket to participate.
National Library of Medicine, 2024
of clinical trial timeline delays trace back to recruitment and retention failures
4 out of 5 clinical trials face delays rooted in recruitment and retention. These delays end up costing sponsors in replacement and recruitment.
BioPharma Dive
Two assumptions that don't hold up
Stipends cover it.
Pharma stipends help, but rarely cover the full cost -- parking, childcare, lost wages, co-pays, mental health, and daily life expenses remain unaddressed.
Decentralized trials solve this.
Remote and hybrid designs reduce travel but introduce new barriers -- home health logistics, caregiver strain, connectivity, and the same financial pressures.
WHAT WE DO
Technology-Enabled Retention Infrastructure with a Human in the Loop
Free and discounted travel, hotels, meals, gas cards, childcare, and financial assistance — for the patient and the caregiver. Deployed around a trial, a launch, or a whole franchise, with no site software to install and no new burden on coordinators or staff.
Keep patients in the trial
Matching a patient to a trial is not the same as getting them there. They still have to reach the site — then live near it for weeks. We Are Here's proprietary database includes more than 20,000 resources that can secure free and discounted travel, hotels, meals, and gas cards for patients and their caregivers. Participants have received $10,000–$21,000+ in assistance across six months to help them finish.
Retention

Matching the right resources for each patient needs
Every patient hits a different wall. We Are Here matches 24 patient characteristics against 160 resource characteristics to generate best-fit support instantly — proactive and need-based, including the needs patients don't know to ask about. A navigator reviews and approves every recommendation before it reaches the patient, and the model learns from real outcomes every day.

See retention as it happens
Support you can't measure can't be managed. Sponsors and sites get real-time, aggregate dashboards — support categories used, financial and transportation assistance connected, time-to-first-resource, and patient-reported distress and loneliness trends. It's the retention signal you look for, and every figure is anonymized, so no individual patient's data ever crosses the line.

Nightly AI validation confirms every resource link is live, compliant, and -- for financial resources -- actively funded.
Beyond the Trial
Enrollment isn't the
finish line.
Patients leave trials for reasons that have nothing to do with the science — and everything to do with the cost and load of participating. See where that load sits today, and where We Are Here picks it up.
Patient Barrier
Covered by the trial today

Financial (lost wages, childcare)
Partial (stipend)
✓
Logistical (travel, relocation, scheduling)
Partial
✓
Emotional (distress, isolation, fear)
Out of scope
✓
Administrative (insurance, eligibility, applications)
Out of scope
✓
Independent and non-promotional: resources are vetted third parties, support is need-based and therapy-agnostic — designed to keep sponsors at arm's length from individual patient decisions.
Every day of delay has a price tag
Let's start with a conversation
Any study struggling to improve operational efficiency or retention, can be mapped to where patients are at most risk of dropping out — and what a We Are Here deployment around it looks like.
